The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
about
Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case seriesGenetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary SyndromePolycystic ovary syndrome in adolescence.Hirsutism.In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced ratsDevelopmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheepMetformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.Similar causes of various reproductive disorders in early lifeInsulin resistance and fertility in polycystic ovary syndromeEffects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Could oxidative stress influence the in-vitro maturation of oocytes?PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Dysglycemia and a history of reproductive risk factorsPeroxisome proliferator-activated receptors: new players in the field of reproduction.Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.Insulin and hyperandrogenism in women with polycystic ovary syndrome.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Use of metformin in the treatment of polycystic ovary syndrome.Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.Clinical outcome of various metformin treatments for women with polycystic ovary syndrome.Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response.Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome.Why AMPK agonists not known to be stressors may surprisingly contribute to miscarriage or hinder IVF/ART.Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review
P2860
Q24645442-E19554CF-87FE-4CFC-864B-65E825A0071DQ26745164-82FC2DF2-1D6C-479F-B0FD-84F38B576164Q30446398-4AD5EB59-C31B-46FF-8C6B-DA5060250D4AQ33310485-9D0F620D-AD13-46A0-860B-AB6E9149CD7BQ33797004-0E029EFC-6219-44B5-B075-F3B2F75E4F9AQ33878849-F9716D9A-BD52-42C4-A7CC-70D5FFFA2F27Q34132558-BD52A423-32C5-4B0A-BDE8-3CFA00411F86Q34148029-D810EF0F-D31B-4A1B-90E3-547357A2AD89Q34394422-9F7A44CD-D241-419B-BE14-2343D322DD51Q34480793-EE68ADB7-12B3-44CC-9396-BA65F59D28A6Q34729110-38B67200-2778-45B4-B87D-6C39429D855AQ35233754-F9F1B4B1-444C-4FD2-8663-2668B4230620Q35606245-5850FA24-C2C6-4382-A588-E13EE46808DBQ36465006-89BF4AC6-098F-4C62-AC8A-A54A74BF8E9EQ36807469-1DEAFCAB-AF54-4D1D-88DB-5B281F267B14Q36903108-87AB6F58-62E7-436B-9DDE-F8CC5B6869ADQ37106561-CB918DE7-6AE0-4394-A5B4-6BE6ED3910D1Q37355746-BCEF5A06-5CC7-4BE8-A81B-0DE6922B7AF5Q37570577-41512731-1CD8-4CC0-A47B-6A5545313F72Q37769526-5004EC3D-B9B2-4D9B-BB98-A91F2621F5DFQ44343498-89CBF4A0-CDD9-4F60-8F55-0895DEAC467CQ46496422-DCAF29E2-EF77-4310-9DBD-D6724D6DE5EFQ47094213-F26C0789-BD2D-4A2B-8DD4-BC294511406FQ47118292-E8527790-4C3E-415F-B069-32A1449BAA0AQ51037574-5FAF5391-1F22-46CB-A782-F3C31312D0D7Q54976706-10FE09BE-76DF-4337-B04F-7B951DFDCB83Q57473711-09EFE172-860F-433A-9574-CEF718945849
P2860
The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@en
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@nl
type
label
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@en
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@nl
prefLabel
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@en
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P921
P356
P1476
The effects of rosiglitazone a ...... ith polycystic ovary syndrome.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03345339
P577
2005-12-01T00:00:00Z